Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells

被引:138
作者
Dallari, D.
Savarino, L.
Stagni, C.
Cenni, E.
Cenacchi, A.
Fornasari, P. M.
Albisinni, U.
Rimondi, E.
Baldini, N.
Giunti, A.
机构
[1] Ist Ortoped Rizzoli, Div 7, Lab Pathophysiol Orthopaed Implants, Blood Transfus Serv, I-40136 Bologna, Italy
[2] Ist Ortoped Rizzoli, Serv Radiol & Diagnost Immagini, I-40136 Bologna, Italy
关键词
D O I
10.2106/JBJS.F.01026
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: There is great interest in the use of bone substitutes to improve bone repair. We compared the osteogenic potential of lyophilized bone chips combined with platelet gel, or with platelet gel and bone marrow stromal cells, with that of lyophilized bone chips alone in the healing of a high tibial osteotomy. Methods: A prospective, randomized, controlled study was performed, and a standardized clinical model was applied. Thirty-three patients undergoing high tibial osteotomy to treat genu varum were enrolled and assigned to three groups. During the osteotomy, lyophilized bone chips with platelet gel were implanted into eleven patients (Group A), lyophilized bone chips with platelet gel and bone marrow stromal cells were implanted in twelve patients (Group 13), and lyophilized bone chips without gel were placed in ten patients as controls (Group C). Six weeks after surgery, computed tomography-guided biopsies of the grafted areas were performed and the specimens were analyzed by histomorphometry. Clinical and radiographic evaluation was performed at six weeks, twelve weeks, six months, and one year after surgery. Results: Histomorphometry at six weeks showed significantly increased osteoblasts and osteoid areas in both Group A (p = 0.006 and p = 0.03, respectively) and Group B (p = 0.009 and p = 0.001) in comparison with controls, as well as increased bone apposition on the chips (p = 0.007 and p = 0.001, respectively), which was greater in Group B than in Group A (p < 0.05). Group B showed significantly higher revascularization than the controls (p = 0.004). Radiographs revealed a significantly higher rate of osseointegration in Groups A and B than in the controls at six weeks (p < 0.005 and p < 0.0001, respectively). At the final evaluation at one year, the osseointegration was still better in Groups A and B than in Group C; however, all patients had complete clinical and functional evidence of healing. Conclusions: Adding a platelet gel or a platelet gel combined with bone marrow stromal cells to lyophilized bone chips increases the osteogenetic potential of the lyophilized bone chips and may be a useful tool in the treatment of patients with massive bone loss.
引用
收藏
页码:2413 / 2420
页数:8
相关论文
共 42 条
  • [1] Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
  • [2] Bhanot Sumeet, 2002, Facial Plast Surg, V18, P27, DOI 10.1055/s-2002-19824
  • [3] Cancedda R., 2003, NOVARTIS FDN S, V249, P239
  • [4] Cancedda R, 2003, NOVART FDN SYMP, P170
  • [5] Cancedda Ranieri, 2003, Novartis Found Symp, V249, P133
  • [6] Mesenchymal stem cells: building blocks for molecular medicine in the 21st century
    Caplan, AI
    Bruder, SP
    [J]. TRENDS IN MOLECULAR MEDICINE, 2001, 7 (06) : 259 - 264
  • [7] Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts
    Cenni, E
    Ciapetti, G
    Pagani, S
    Perut, F
    Giunti, A
    Baldini, N
    [J]. JOURNAL OF PERIODONTOLOGY, 2005, 76 (03) : 323 - 328
  • [8] Effect of platelet-rich plasma on bone regeneration in autogenous bone graft
    Choi, BH
    Im, CJ
    Huh, JY
    Suh, JJ
    Lee, SH
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 33 (01) : 56 - 59
  • [9] Human bone marrow stromal cells: In vitro expansion and differentiation for bone engineering
    Ciapetti, G.
    Ambrosio, L.
    Marletta, G.
    Baldini, N.
    Giunti, A.
    [J]. BIOMATERIALS, 2006, 27 (36) : 6150 - 6160
  • [10] In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination
    Dallari, D
    Fini, M
    Stagni, C
    Torricelli, P
    Aldini, NN
    Giavaresi, G
    Cenni, E
    Baldini, N
    Cenacchi, A
    Bassi, A
    Giardino, R
    Fornasari, PM
    Giunti, A
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 2006, 24 (05) : 877 - 888